周叶冰 / Zhou Yebing

周叶冰 / Zhou Yebing is the genetics PhD and U.S. pharmaceutical-company immunology researcher appearing in E227｜美国医疗市场AI争夺战：巨头押注，创业公司能赢吗？. His role is to keep the medical AI discussion grounded in clinical workflow, evidence quality, patient context, and the realities of biomedical research.

He repeatedly pulls the conversation away from “AI doctor” abstraction. In his framing, AI can help doctors search new literature, organize complex information, and support triage, but users must ask for evidence and reasoning, and doctors remain responsible for diagnosis and treatment judgment.

Key Points

• Zhou explains why doctors and pharma researchers are cautious about uploading sensitive information into ordinary external models.
• He treats OpenEvidence as useful because doctors need stronger evidence grounding than general-purpose chatbot answers often provide.
• He argues that users should ask AI for sources, reasoning, and evidence level rather than only accepting the first answer.
• His position reinforces Human Judgment Under AI, Evidence-Grounded Medical RAG, and Online Healthcare Regulatory Boundary.

Connections

• 硅谷101 and 张璐 / Zhang Lu — episode context and co-guest.
• OpenEvidence, HealthBench, and Medical Literature Search — evidence and evaluation branch.
• AI Health Management, Personal Health Data, and Human Judgment Under AI — consumer health and clinician responsibility context.